Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Home
Johnson Matthey Plc
Completion of Diagnostic Services sale
Business
Oct 2 2023
5 min read

Completion of Diagnostic Services sale

2nd October 2023

 

Johnson Matthey Plc

(the Company)


Johnson Matthey announces completion of Diagnostic Services (also known as Tracerco) sale

 

Further to the announcement on 3rd May 2023, Johnson Matthey Plc (JM) is pleased to announce that it has completed the sale of its Diagnostic Services business on 29th September 2023 in accordance with the terms of the sale agreement entered into between JM and Sullivan Street Partners for a consideration of £55 million.

 

 

About Johnson Matthey

Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, we improve the performance, function and safety of our customers' products. Our science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet's natural resources. Today more than 15,000 Johnson Matthey professionals collaborate with our network of customers and partners to make a real difference to the world around us. For more information, visit www.matthey.com

 

 

ENDS

 

Enquiries: 

 



Investor Relations

Martin Dunwoodie

Louise Curran

Carla Fabiano

 

Director of Investor Relations

Senior Investor Relations Manager

Senior Investor Relations Manager

 

020 7269 8241

020 7269 8235

020 7269 8004

 

Media

Harry Cameron

 

 

Teneo

 

 

020 7353 4200

 

 



 

 

Johnson Matthey Plc is listed on the London Stock Exchange (JMAT)

Registered in England & Wales number: 00033774
Legal Entity Identifier number: 2138001AVBSD1HSC6Z10